No abstract available
MeSH terms
-
Adrenal Gland Neoplasms / drug therapy
-
Adrenal Gland Neoplasms / secondary
-
Aged
-
Amiodarone / administration & dosage
-
Anti-Arrhythmia Agents / administration & dosage
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / adverse effects*
-
Atrial Fibrillation / drug therapy
-
Biomarkers / blood
-
Bone Neoplasms / drug therapy
-
Bone Neoplasms / secondary
-
Carcinoma, Renal Cell / drug therapy*
-
Carcinoma, Renal Cell / secondary*
-
Drug Administration Schedule
-
Fatal Outcome
-
Heart Arrest / etiology
-
Humans
-
Kidney Neoplasms / pathology
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / secondary
-
Male
-
Muscle Neoplasms / drug therapy
-
Muscle Neoplasms / secondary
-
Niacinamide / administration & dosage
-
Niacinamide / adverse effects
-
Niacinamide / analogs & derivatives*
-
Phenylurea Compounds / administration & dosage
-
Phenylurea Compounds / adverse effects*
-
Protein Kinase Inhibitors / administration & dosage
-
Protein Kinase Inhibitors / adverse effects*
-
Protein-Tyrosine Kinases / antagonists & inhibitors*
-
Respiratory Aspiration / complications
-
Sorafenib
-
Thyroid Crisis / blood
-
Thyroid Crisis / chemically induced*
-
Thyroid Crisis / diagnosis
-
Thyroid Hormones / blood*
Substances
-
Anti-Arrhythmia Agents
-
Antineoplastic Agents
-
Biomarkers
-
Phenylurea Compounds
-
Protein Kinase Inhibitors
-
Thyroid Hormones
-
Niacinamide
-
Sorafenib
-
Protein-Tyrosine Kinases
-
Amiodarone